Strizova, Z.; Kuchar, M.; Capkova, L.; Komarc, M.; Skrivan, J.; Bartunkova, J.; Plzak, J.; Smrz, D.
Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response. Biomedicines 2021, 9, 402.
https://doi.org/10.3390/biomedicines9040402
AMA Style
Strizova Z, Kuchar M, Capkova L, Komarc M, Skrivan J, Bartunkova J, Plzak J, Smrz D.
Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response. Biomedicines. 2021; 9(4):402.
https://doi.org/10.3390/biomedicines9040402
Chicago/Turabian Style
Strizova, Zuzana, Martin Kuchar, Linda Capkova, Martin Komarc, Jiri Skrivan, Jirina Bartunkova, Jan Plzak, and Daniel Smrz.
2021. "Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response" Biomedicines 9, no. 4: 402.
https://doi.org/10.3390/biomedicines9040402
APA Style
Strizova, Z., Kuchar, M., Capkova, L., Komarc, M., Skrivan, J., Bartunkova, J., Plzak, J., & Smrz, D.
(2021). Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response. Biomedicines, 9(4), 402.
https://doi.org/10.3390/biomedicines9040402